PRAX - Praxis Precision Medicines, Inc.

QQQ $ 446.25 $ -12.35 (-2.68 %)

DIA $ 404.28 $ -3.99 (-0.98 %)

SPY $ 539.90 $ -9.25 (-1.68 %)

TLT $ 99.49 $ -0.01 (-0.01 %)

GLD $ 230.65 $ -1.72 (-0.74 %)

Previous Close

$ 54.02

Open

Bid

$ 53.86 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 13.01 - $ 67.21

Volume

171,413

Average Volume

Market Cap

959.24M

Beta (5Y Monthly)

$ -0.06

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2024	06-30-2024	10-Q
2	05-13-2024	03-31-2024	10-Q
3	03-05-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-09-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	02-07-2023	12-31-2022	10-K
8	11-09-2022	09-30-2022	10-Q
9	08-08-2022	06-30-2022	10-Q
10	05-09-2022	03-31-2022	10-Q
11	02-28-2022	12-31-2021	10-K
12	11-03-2021	09-30-2021	10-Q
13	08-16-2021	06-30-2021	10-Q
14	05-11-2021	03-31-2021	10-Q
15	03-17-2021	12-31-2020	10-K
16	11-23-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Reiterates Buy on Praxis Precision...
09/05/2024 10:22:19

Needham analyst Ami Fadia reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $151 price target.

Forecasting The Future: 14 Analyst Project...
09/04/2024 21:00:25

Oppenheimer Reiterates Outperform on Praxi...
09/04/2024 14:14:53

Oppenheimer analyst Francois Brisebois reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and raises the p...

Philip Morris International To Rally More ...
09/04/2024 13:38:55

Praxis Precision Medicines To Highlight Th...
09/04/2024 12:02:07

Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into th...

Needham Maintains Buy on Praxis Precision ...
09/04/2024 09:32:47

Needham analyst Ami Fadia maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $145...

HC Wainwright & Co. Reiterates Buy on Prax...
09/03/2024 17:34:26

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $12...

praxis-precision-medicines-touts-encouraging-data-for-mid-stage-epilepsy-drug

Praxis Precision Medicines Touts Encouragi...
09/03/2024 16:18:40

Praxis Precision Medicines reports positive Phase 2 EMBOLD study results for relutrigine in treating SCN2A and SCN8A developmen...

Needham Reiterates Buy on Praxis Precision...
09/03/2024 14:28:34

Needham analyst Ami Fadia reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $145 price target.

Praxis Precision Medicines shares are trad...
09/03/2024 12:53:04

Praxis Precision Medicines Announced Topli...
09/03/2024 11:32:19

Reported Earlier, Praxis to Reveal Phase 2...
09/03/2024 07:01:48

Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into th...

HC Wainwright & Co. Maintains Buy on Praxi...
08/15/2024 10:26:22

HC Wainwright & Co. analyst Douglas Tsao maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the pri...

these-analysts-increase-their-forecasts-on-praxis-precision-medicines-after-q2-results

These Analysts Increase Their Forecasts On...
08/14/2024 19:14:59

Wedbush Maintains Neutral on Praxis Precis...
08/14/2024 17:38:18

Wedbush analyst Laura Chico maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Neutral and raises the price target fro...

Oppenheimer Reiterates Outperform on Praxi...
08/14/2024 17:31:18

Oppenheimer analyst Francois Brisebois reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and maintains $1...

Guggenheim Maintains Buy on Praxis Precisi...
08/14/2024 17:21:53

Guggenheim analyst Yatin Suneja maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target fro...

Needham Reiterates Buy on Praxis Precision...
08/14/2024 09:33:20

Needham analyst Ami Fadia reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $145 price target.

Praxis Precision Medicine Q2 2024 GAAP EPS...
08/13/2024 11:14:25

Praxis Precision Medicine (NASDAQ:PRAX) reported quarterly losses of $(1.74) per share which beat the analyst consensus estimat...

Needham Reiterates Buy on Praxis Precision...
08/12/2024 09:29:35

Needham analyst Ami Fadia reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $145 price target.